Spanish Hipra vaccine to test its fourth dose
STORY: Spanish Hipra vaccine to test its fourth dose
DATELINE: Sept. 1, 2022
LENGTH: 00:01:34
LOCATION: Madrid
CATEGORY: HEALTH
SHOTLIST:
1. various of HIPRA Laboratories
2. various of people at hospital
STORYLINE:
The Spanish pharmaceutical company HIPRA has announced that it will start a clinical trial in 10 hospitals at the end of this summer to study the effectiveness of its vaccine as a possible fourth dose to protect against COVID-19.
Each of the 10 hospitals will test 200 volunteers, who have previously received 3 doses of a different vaccine (such as Pfizer-BioNTech), to discover the immune response and evaluate the safety of the HYPRA vaccine as a second 'booster' dose.
The HYPRA vaccine is currently pending approval by the European Medicines Agency (EMA) in order to be marketed.
The hospitals will start the trial once permission has been received from the Spanish Agency for Medicines and Health Products (AEMPS) and the Ethics Committee for Research with Medicines of the Hospital Clinic d
- Product Code
- ILEA001011853
- Registered date
- 2022/9/01 00:00:00
- Credit
- Xinhua / Kyodo News Images
- Media source
- Xinhua News Agency.All Rights Reserved
- Media size
- 1920 × 1080 pixel
- Deployment size
- 100.27(MB)*
*File size when opened in Photoshop, etc.